---
title: "Sensei Biotherapeutics Insiders Sold Shares Worth Over $1.0M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288331208.md"
description: "On June 1, 2026, Sensei Biotherapeutics insiders Peyer James and Cambrian Biopharma Inc., both 10% owners, sold shares worth over $1.0 million combined. Each reported selling stock with a weighted average price of $20.00 per share for proceeds of $500,542. Both entities retained beneficial ownership of 130,142 shares following these transactions, as disclosed in Form 4 filings."
datetime: "2026-06-01T21:30:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288331208.md)
  - [en](https://longbridge.com/en/news/288331208.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288331208.md)
generator: "portal-rs"
---

# Sensei Biotherapeutics Insiders Sold Shares Worth Over $1.0M

Peyer James, identified as a 10% owner, reported sales of common stock on 2026-06-01 with a weighted average selling price of $20.00 per share (prices ranged from $20.00 to $21.00) for total proceeds of $500,542 for 25,000 shares sold, and directly beneficially owns 130,142 shares of common stock following the transactions.

Cambrian Biopharma, identified as a 10% owner, reported the sale of common stock on 2026-06-01 that included a larger block with a weighted average selling price of $20.00 per share and an individual sale at $21.14 per share, for total proceeds of $500,542, and directly owns 130,142 shares of common stock following the transactions.

| Reporter Name          | Relationship | Type | Amount   | SEC Filing |
| ---------------------- | ------------ | ---- | -------- | ---------- |
| Peyer James            | 10% Owner    | Sell | $500,542 | Form 4     |
| Cambrian Biopharma Inc | 10% Owner    | Sell | $500,542 | Form 4     |

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [SNSE.US](https://longbridge.com/en/quote/SNSE.US.md)
- [FTH.US](https://longbridge.com/en/quote/FTH.US.md)

## Related News & Research

- [Insider Selling: Riskified (NYSE:RSKD) Director Sells $22,590.81 in Stock](https://longbridge.com/en/news/297901364.md)
- [First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M](https://longbridge.com/en/news/298073734.md)
- [Insider Selling: Fastly (NASDAQ:FSLY) CEO Sells 9,458 Shares](https://longbridge.com/en/news/298080695.md)
- [Insider Selling: CeriBell (NASDAQ:CBLL) CEO Sells 39,540 Shares](https://longbridge.com/en/news/298109186.md)
- [Have Beta Bionics Insiders Been Selling Stock?](https://longbridge.com/en/news/298111067.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**